Results 1 to 10 of about 3,251,105 (390)

Antipsychotic agents: efficacy and safety in schizophrenia [PDF]

open access: yesDrug, Healthcare and Patient Safety, 2012
Arão Nogueira de Araújo,1 Eduardo Pondé de Sena,1,2 Irismar Reis de Oliveira,1,3 Mario F Juruena41Postgraduation Program in Interactive Processes of Organs and Systems, 2Department of Pharmacology, Institute of Health ...
de Araújo AN   +3 more
doaj   +7 more sources

Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. [PDF]

open access: goldPLoS One, 2018
Bacterial antibiotic resistance is an emerging public health problem worldwide; therefore, new therapeutic strategies are needed. Many studies have described antipsychotic compounds that present antibacterial activity.
Nehme H   +6 more
europepmc   +4 more sources

Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons. [PDF]

open access: goldJ Am Heart Assoc, 2015
Background Data from observational studies have raised concerns about the safety of treatment with antipsychotic agents (APs) in elderly patients with dementia, but this area has been insufficiently investigated. We performed a head-to-head comparison of
Sahlberg M   +5 more
europepmc   +4 more sources

Use of second-generation antipsychotic agents for sleep and sedation: a provider survey. [PDF]

open access: bronzeSleep, 2013
OBJECTIVES Anecdotal evidence suggests that second-generation antipsychotic agents are increasingly used to treat sleep problems. This study sought to quantify the proportion of new prescriptions for second-generation antipsychotic agents started for ...
Hermes ED, Sernyak M, Rosenheck R.
europepmc   +4 more sources

Antipsychotic Agents: A Clinical Update [PDF]

open access: bronzeMayo Clinic Proceedings, 1985
Antipsychotic agents have many indications and are frequently used. All physicians, regardless of their subspecialty, will most likely treat patients who receive these drugs. This article is designed to help nonpsychiatric physicians use antipsychotics appropriately.
Jarrett W. Richardson   +2 more
openaire   +4 more sources

QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy [PDF]

open access: yesAnnals of General Psychiatry, 2005
Background Several antipsychotic agents are known to prolong the QT interval in a dose dependent manner. Corrected QT interval (QTc) exceeding a threshold value of 450 ms may be associated with an increased risk of life threatening arrhythmias ...
Piccinelli Marco   +9 more
doaj   +5 more sources

Existing and emerging pharmacological approaches to the treatment of mania: A critical overview [PDF]

open access: yesTranslational Psychiatry, 2022
Manic episodes are a defining, frequent and dramatically disabling occurrence in the course of Bipolar Disorder type I. Current pharmacotherapy of mania lists a good number of agents, but differences in efficacy and safety profiles among these agents ...
Giulio Sparacino   +3 more
doaj   +2 more sources

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia

open access: yesNeuropsychiatric Disease and Treatment, 2009
Xinhua S Ren1,2,3, Lawrence Herz4,5, Shirley Qian1,2,3, Eric Smith3,4, Lewis E Kazis1,2,31The Center for the Assessment of Pharmaceutical Practices (CAPP), Boston University School of Public Health, Boston, MA, USA; 2Department of ...
Xinhua S Ren   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy